Bill McCarberg, MD
Kaiser Permanente
San Diego, CA
John Hairston, MD
Associate Professor, Department of Urology
Feinberg School of Medicine, Northwestern University
Bill McCarberg MD is Founder of the Chronic Pain Management Program for Kaiser
Permanente in San Diego, California. He is on the board of directors of the American Academy
of Pain Medicine and the National Pain Foundation. He is president of the Western Pain Society
and Adjunct Assistant Clinical Professor at the University of California at San Diego School
Medicine. Dr McCarberg is a member of the American Academy of Family Physicians, the
American Academy of Pain Medicine, the American Pain Society, and the International
Association for the Study of Pain. He is the recipient of several awards including the Shilling
Compassionate Care Award, the Elizabeth Narcessian award for leader in the field of pain
education from the American Pain Society and in 2008 was Ambassador of the Year for the
National Pain Foundation. Member
Appraisal of Physician Services at Kaiser Permanente rated Dr. McCarberg in the top 10% from
1998 until the present. He has given more than 250 presentations on pain management issues
and is the author or co-author of 80 articles, book chapters and books. He is board certified by
the American College of Pain Medicine, the American Board of Family Practice and additionally
certified in Geriatrics. Dr McCarberg received his MD degree from Northwestern University
Medical School in Chicago, Illinois. He completed a medical internship and a residency in
family practice at Highland Hospital in Rochester, New York.
Jon W. Draud, MS, MD
Medical Director of Psychiatry and Addiction Medicine,
Baptist Hospital, Nashville, Tennessee

Jon W. Draud, MS, MD is currently in the private practice of psychopharmacology and adult
psychiatry at Heritage Medical Associates, PC. He is also Medical Director of Psychiatry and
Addiction Medicine Services at Baptist Hospital, and he is on the Clinical Faculty in the
Department of Psychiatry at Vanderbilt University in Nashville, Tennessee.
Dr. Draud received his MS in Pharmacology and his MD at the University of Kentucky in
Lexington. He received postgraduate medical education at Vanderbilt University in Nashville,
where he completed a residency in Psychiatry. A Diplomate of the American Board of Psychiatry
and Neurology, Dr. Draud is a member of the American Psychiatric Association, American
Medical Association, and the American Academy of Psychiatry and Law and American Academy
of Sleep Medicine. He is active in teaching medical students and residents, and he has
delivered over 1,500 professional lectures to medical personnel. Dr. Draud serves on
numerous advisory boards, is an active, national-level speaker for several companies, and is
involved in neurobiological initiatives related to psychiatric illness. Dr. Draud has been involved
in design and implementation of several neurobiology projects, including the disease states of
depression, bipolar disorder, insomnia and pain with an emphasis on fibromyalgia and
neuropathic pain. Most recently, he was appointed by the MJ consulting group to its
Neuroscience Advisory Council and is one of four founding members of the Integrative
Neurobiology Educational Institute which is a nationally based "think tank" aimed at raising
public awareness about the neurobiological underpinnings common among many psychiatric
disease states.
Steven T. Harris, MD
Clinical Professor of Medicine
University of California, San Francisco
Rakesh Jain, MD, MPH, is Director of Psychiatric Drug Research for the R/D Clinical Research
Center at Lake Jackson, Texas.
Dr. Jain attended medical school at the University of Calcutta in India. He then attended
graduate school at the University of Texas School of Public Health in Houston, where he was
awarded a National Institute/Center for Disease Control Competitive Traineeship. His research
thesis focused on alcohol abuse issues. He graduated from the School of Public Health in
1987 with a Masters of Public Health (MPH) degree. After graduate school, Dr. Jain completed a
postdoctoral fellowship in Research Psychiatry with the Gerontology Center of the University of
Texas Mental Sciences Institute in Houston. He received the National Research Service Award
for the support of the postdoctoral fellowship. After this, he served a three-year residency in
Psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas
Medical School at Houston as well as a two-year fellowship in Child
and Adolescent Psychiatry.
Dr. Jain is currently involved in multiple research projects studying the effects of medications on
short-term and long-term treatment of depression, anxiety, pain/mood overlap disorders, and
psychosis in adult and child/adolescent populations. He is the author of several articles on the
issue of mood and pain conditions. He serves on several Boards focusing on drug
development and disease state
education. He was recently named “Public Citizen of the Year” by the National Association of
Social Workers, Gulf Coast Chapter, in recognition of community and peer education and
championing of mental health issues. He was also recently awarded the “Extra Mile Award” by
the local school district, in recognition of the service to the children of the school district and
consultation to the teachers and counselors.
Robert Friedland, MD
Professor and Chairman
Department of Neurology
University of Louisville School of Medicine
Dr Friedland is a clinical and research neurologist interested in behavior and aging. He is a
graduate of the City College of New York and the Mount Sinai School of Medicine (1973). He
completed his neurology residency at the Mount Sinai Hospital in New York and from 1977-
1978 was a Fellow in dementia and aging under Dr. Robert Katzman at the Albert Einstein
College of Medicine, NY. Since then he has worked at the University of California Davis and the
Research Medicine Group of the Lawrence Berkeley Laboratory of the University California,
Berkeley. He served from 1985 to 1990 as Deputy Clinical Director and Chief of the Section on
Brain Aging and Dementia of the National Institute on Aging Institute, National Institutes of
Health, Bethesda, MD. Since 1990 he has worked at Case Western Reserve University in the
School of Medicine, where he is currently Professor of Neurology and Psychiatry and Chief of the
Laboratory of Neurogeriatrics. Dr. Friedland’s work has focused on clinical and biological
issues in Alzheimer’s disease and related disorders. He was among the first to document
patterns of abnormal brain metabolism and cerebral blood flow in the disease using positron
emission and single photon emission computed tomography. He also contributed early studies
on the use of magnetic resonance imaging in dementia. The first studies of problems of driving
behavior in patients with Alzheimer’s disease came from his group at the NIH. More recently, Dr.
Friedland has been working on the patterns of disease occurrence and risk and protective
factors, with studies of the Kikuku in Kenya, Jews and Arabs in Israel and Caucasian and
African-American subjects in Cleveland. He has documented a series of important
determinants of the disease, including physical and mental inactivity, smoking and diet. This
work has focused on interactions of genetic and environmental lifestyle elements. His group is
also using animal models to better define the pathophysiology of Alzheimer’s disease and
develop new treatments.


Dr. Harris is a board-certified internist and endocrinologist with a subspecialty focus on
osteoporosis, metabolic bone disease and disorders of mineral metabolism. He received his
medical degree from the University of California, San Francisco, and completed a residency and
chief residency in Internal Medicine at the same institution. He completed a clinical and research
fellowship in Endocrinology and Metabolism at Massachusetts General Hospital in Boston. In
1983, he returned to the University of California, San Francisco, where he is a Clinical Professor of
Medicine. Dr. Harris has spent many years working on a variety of clinical research projects to
examine the effects of nutrition, calcium supplements, vitamin D, hormone therapy,
bisphosphonates, calcitonin, PTH (parathyroid hormone) and SERMs (selective estrogen receptor
modulators) upon the prevention and treatment of osteoporosis. Dr. Harris maintains an active
consultative practice in metabolic bone disease, but is also engaged in a wide variety of
educational initiatives related to osteoporosis.

Dr. Hairston obtained his medical degree from The University of Texas Medical School at Houston
prior to completing his general surgery and urologic residency training with Northwestern
University in Chicago, Illinois. Following residency, Dr. Hairston completed a fellowship in Female
Urology, Voiding Dysfunction and Pelvic Reconstruction at Cleveland Clinic Florida in Weston, FL.
He was previously on faculty at UT-Houston where he was Chief of Urology at the Institute for
Rehabilitation and Research (TIRR). He joined the faculty at Northwestern University Department
of Urology as Associate Professor of Urology in the winter of 2009.
Dr. Hairston’s clinical interests include male and female incontinence, voiding dysfunction and
pelvic reconstruction. He holds a particular interest in voiding dysfunction from neurologic causes
such as spinal cord injury, multiple sclerosis, stroke, etc. During his time at the Texas Medical
Center, Dr. Hairston spearheaded development of a robotic bladder reconstruction program for
patients with neurogenic bladder, a first of its kind in the world. His research efforts have included
trials encompassing the prevention of UTIs in spinal cord injury patients, a placebo-controlled trial
for treating Interstitial Cystitis, and investigation on the safety and efficacy of the urethral bulking
agent Macroplastique for the treatment of female urinary stress incontinence.
In addition to serving on panel for a number of prestigious journals, Dr. Hairston is a member of
several associations and organizations, such as the American Urological Association, the
International Continence Society, the Society for Urodynamics and Female Urology, the
International Urogynecology Association, and the American Spine Injury Association.
Rakesh Jain, MD, MPH
Director, Psychiatric Drug Research
R/D Clinical Research Center
Lake Jackson, Texas